Clinical Trial Update: Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a salmeterol xinafoate and fluticasone propionate inhalation powder in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• Salmeterol Xinafoate (salmeterol xinafoate)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Asthma | Phase 3 | Status: UNKNOWN